PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 17, 2026Journal of Pharmaceutical Policy and Practice1 citationsOpen Access

The registration status of maternal, newborn, and child health medical products: evidence from 9 countries

View Full Paper
JBJane BriggsKKKate KikuleHWHelena Walkowiak

Key Points

  • Evaluate the registration status of maternal, newborn, and child health medical products across nine countries.
  • Analyzed registration processes in selected countries.
  • Identified flaws in national systems for medical product registration.
  • Assessed the availability of essential MNCH products.
  • Many life-saving MNCH products are unavailable due to flawed registration processes.
  • Recommendations include prioritizing the registration of public health medicines.
  • Streamlining procedures is essential to improve health for women and children.

Abstract

Some life-saving MNCH products are not available because national registration processes are flawed. Consequently, governments and donors must invest in changes to streamline procedures to register vital medicines to protect the health of women and children. To maximise health outcomes, countries should prioritise the registration of products of public health importance, including MNCH medicines.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Briggs et al. (2026) studied this question.

synapsesocial.com/papers/69e1cd6f5cdc762e9d856ecdhttps://doi.org/10.1080/20523211.2026.2635754
Ask AI
Helpful
Bookmark
Share
View Full Paper